transaction to invest in the common stock of BS Myco Biotech Company Limited that operate in the Biopharmaceutical products with purchase from Bangjak Green Energy Company Limited total 399,990 shares or 85.65
55,000,000 shares 1.2 The determination of the offering price and the market price The Company considers the appropriate of the offering price based on financial position, performance, Book Value per share
Acquisition of Assets and the Connected Transaction 2. Information Memorandum regarding the offering of the newly issued ordinary shares to specific investors (Private Placement) 3. Capital Increase Report Form
stock price in terms of supply and demand in the SET that actual trading of the Company's shares based on the investor's investment. Investors are able to receive information and news about the Company
on comparision value of securities N/A, Can not be calculated due to not issuing shares to pay for assets - The transaction will have the maximum transaction size based on the criteria on total value
; (b) an individual or a company holding majority shares of such person, which means: 1. an individual or a company holding shares of such person in the number of exceeding fifty percent of the total
company holding majority shares of such person, which means: 1. an individual or a company holding shares of such person in the number of exceeding fifty percent of the total paid-up shares with voting
Share Purchase Agreement (“SPA”) to sell 3,249,998 shares (40.51 percent of the total SBITO’s shares) was signed on July 31, 2017, in which 1,604,444 shares were sold in phase one at the price of 71.49
Page 1 of 2 Ref.GEL.CS.014/2561 9th May 2018 Subject: :The disposition of the common shares held in Prinda Public Company Limited To: :President The Stock Exchange of Thailand Regarding to the Board
related persons 5.1 Mrs.Pensri Phattakayon 0.02 % shares held as the mother of Miss Yada Phattakayon , as the Director 0.29% shares held 5.2 Mrs. Chotika Sirikwanchai 0.07 % shares held as the daughter of